| December 2019 |
| 11 Dec |
Biocon, partner Mylan launch oncology biosimilar trastuzumab in US |
 |
| November 2019 |
| 28 Nov |
USFDA nod to Biocon's new Bengaluru unit |
|
| 28 Nov |
Biocon, Mylan get nod for pegfilgrastim drug |
|
| October 2019 |
| 30 Oct |
Indian company makes it to top 10 best employers in biotech category |
|
| 26 Oct |
Insulin at ₹7 will be a gamechanger for us |
|
| 25 Oct |
Biocon sets $1 billion target for biologics business |
|
| September 2019 |
| 28 Sep |
Life-enabling productlike insulin should be made affordable: Shaw |
|
| 27 Sep |
Biocon plans to halve insulin prices |
|
| 25 Sep |
Blueprint for a Healthy India |
|
| 25 Sep |
Biocon subsidiary acquires Pfizer’s R&D facility in Chennai |
|
| August 2019 |
| 22 Aug |
Ramp-up of biosimilar portfolio to boost Biocon |
|
| July 2019 |
| 30 Jul |
Our aim is to be a global leader in biosimilars biz: Biocon Biologics CEO |
|
| 26 Jul |
Biocon’s net rises 86%, revenue 25% |
|
| 25 Jul |
Biocon net profit grows 72% |
|
| June 2019 |
| 18 June |
Biosimilars, research key drivers for Biocon |
|
| 18 June |
Trastuzumab’s US launch will be a big opportunity for Biocon-Mylan: Shaw |
|
| 15 June |
Biocon’s Bengaluru biologics units get European agency nod |
|
| 8 June |
The First Lady of Biotech |
|
| May 2019 |
| 30 May |
Biocon, Mylan to present data for Ogivri at ASCO meeting |
|
| 23 May |
Canada clears Mylan & Biocon's Biosimilar |
|
| 20 May |
Biologics to boost Biocon business, say analyst |
|
| 9 May |
Biocon drug gets commercial rights to global markets |
|
| April 2019 |
| 30 Apr |
Biosimilars to help Biocon hit $1bn revenue in FY20 |
|
| 27 Apr |
Biologics, research services the golden goose for Biocon |
|
| 26 Apr |
Biocon Q4 net profit up 64% to ₹213.7 crore |
|
| 18 Apr |
Kiran Mazumdar-Shaw conferred with honorary doctorate from Deakin University, Australia |
|
| 12 Apr |
Violence,EVM glitches, missing names:Rocky start to election |
|
| 08 Apr |
Research must be promoted in colleges |
|
| 05 Apr |
ET Prime celebrates Women's Excellence in Business & Innovation |
|
| 05 Apr |
Breakthrough innovation is taking place but we're not leveraging it |
|
| 04 Apr |
Kiran Mazumdar-Shaw conferred with Honorary Doctorate |
|
| 01 Apr |
Biocon Biologics India appoints Dr. Christiane Hamacher as CEO |
|
| March 2019 |
| 29 Mar |
Biocon chief stresses on gender equality |
|
| 19 Mar |
Kiran back as Infy's independent director |
|
| 18 Mar |
Govt Should Scale Up Philanthropic Capital |
|
| 15 Mar |
Cost of select insulin increases up to 20% |
|
| 12 Mar |
Role of Indian women in Science & Technology |
|
| 11 Mar |
The growing share of biosimilars revenue is doing wonders for our business |
|
| 08 Mar |
Biosimilars offer a huge opportunity for Biocon |
|
| 07 Mar |
Future jobs will be different: Shaw |
|
| 03 Mar |
Pharma specialist new CEO of Biocon Biologics |
|
| 02 Mar |
Hamacher is CEO of Biocon Biologics |
|
| February 2019 |
| 28 Feb |
In bid to curb profiteering, govt caps margins of 42 cancer drugs |
|
| 23 Feb |
Shortage of women for leadership roles |
|
| 18 Feb |
Biocon's revenue up 43%; Net profit up 136% |
|
| 13 Feb |
Biocon's Trastuzumab receives approvals in EU |
|
| 09 Feb |
Kiran Mazumdar-Shaw elected member of US-based NAE |
|
| 04 Feb |
Socio-Economic Issues Focus Area of Budget 2019 |
|
| 02 Feb |
Budget Quotes |
|
| 01 Feb |
Biocon, Mylan announce positive CHMP opinion for Fulphila |
|
| January 2019 |
| 31 Jan |
Why Quitting Should Never Be An Option |
|
| 29 Jan |
Stock Reccos |
|
| 28 Jan |
Biosimilars make Biocon stand apart |
|
| 25 Jan |
Biocon Dec quarter net zooms over two-fold to ₹217 Cr |
|
| 20 Jan |
Top-ranked Karnataka doubles down on skill development |
|
| 16 Jan |
Biocon focus may shift to non-insulins |
|
| 13 Jan |
A Briefcase and A Baby |
|
| 12 Jan |
Kiran Mazumdar-Shaw gets second term as Infosys' Lead Independent Director |
|
| 07 Jan |
For India's healthy billion |
|
